Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

Vascular endothelial growth factor (VEGF) and mammalian target of rapamycin are well-known therapeutic targets for renal cell carcinoma (RCC). Sunitinib is an agent that targets VEGF receptors and is considered to be a standard treatment for metastatic or unresectable clear cell RCC (ccRCC). However...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibasaki, Noboru, Yamasaki, Toshinari, Kanno, Toru, Arakaki, Ryuichiro, Sakamoto, Hiromasa, Utsunomiya, Noriaki, Inoue, Takahiro, Tsuruyama, Tatsuaki, Nakamura, Eijiro, Ogawa, Osamu, Kamba, Tomomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482605/
https://www.ncbi.nlm.nih.gov/pubmed/26114873
http://dx.doi.org/10.1371/journal.pone.0130980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482605/
https://www.ncbi.nlm.nih.gov/pubmed/26114873
http://dx.doi.org/10.1371/journal.pone.0130980

Ejemplares similares